FAM207BP

Across TCGA pan-cancer cohorts, FAM207BP RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated FAM207BP data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher FAM207BP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM207BP expression acts as an unfavorable survival marker, although some lineages such as SKCM and DLBC show a favorable association.

LUAD, LIHC, and ACC are the cancer types where FAM207BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.205	0.432	<.001	133	view →
LIHC	DFS	Median	All	0.351	0.512	<.001	69	view →
ACC	DFS	Tertile	All	0.259	0.657	<.001	64	view →
MESO	OS	Tertile	II,III,IV	0.404	0.664	.003	56	view →
LAML	DFS	Median	All	0.259	0.477	.004	40	view →
HNSC	OS	Quartile	All	0.578	0.866	.001	37	view →
KIRP	DFS	Median	All	0.376	0.784	.001	24	view →
THYM	DFS	Median	All	0.615	0.968	.001	23	view →
CESC	OS	Quartile	All	0.809	0.923	.017	20	view →
SKCM	DFS	Median	IV	0.529	0.147	.013	15	view →
COAD	DFS	Quartile	IV	0.299	0.626	.016	15	view →
THCA	DFS	Quartile	II,III,IV	0.455	0.870	.011	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

FAM207BP–LUAD (OS)

Open the LUAD breakdown →